LeMei Pharmaceutical: Guangtou Group plans to increase capital and expand shares in Guangtou Financial Holding by 25.94% of Zhong Heng Group's shares.

Leimei Pharmaceutical announced that its indirectly controlled shareholder Guangtou Group plans to increase the capital and expand the shares of its subsidiary Guangtou Financial Holdings with the 859 million shares of Zhongheng Group it holds. This transaction involves a change in state-owned equity under the same control. After the transaction is completed, Guangtou Financial Holdings will become an indirectly controlled shareholder of the company, while Zhongheng Group will remain a direct controlling shareholder of the company, and Guangxi State-owned Assets Supervision and Administration Commission will remain the actual controller of the company. The above-mentioned equity change is still in the planning stage and requires the approval of state-owned assets and related legal procedures.